Drawing for EMEDPLUS

USPTO serial 90453866

EMEDPLUS

Reviewed by CopyMark Law Group

Reg. 6994135Status 700Registered
Filing date
Status date
Registration date
Mar 7, 2023
Examiner
HUSSAIN, TASNEEM
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EMEDPLUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anne W. Glazer

Anne W. Glazer STOEL RIVES LLP760 SW NINTH AVENUE, SUITE 3000PORTLAND, OR 97205UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable prescription management mobile applicationsACTIVEOct 23, 2013
042Providing a web-based system and online portal featuring technology that enables users to generate, update, access, view, maintain, manage, report, and exchange electronic information and documents; prescription management services, namely, providing temporary use of online non-downloadable software and applications for users to access, view, and manage prescription information, ordering, refills, history, pricing, billing, and payments; software as a service (SAAS) services featuring software for use by physicians to generate, update, access, view, maintain, manage, report, and exchange prescription information and to enable physicians to electronically order, approve, and report prescription medications and refills; software as a service (SAAS) services featuring software for pharmacy management, electronic health record (EHR) management, integrated prescription management, database management, data processing, legal and regulatory compliance and reporting, prescription drug inventory management, patient eligibility and insurance coverage, prescription synchronization, prescription refills, pharmacy pricing and authorization, delivery management, content management, process automation, and pharmacy data analyticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 7, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 7, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 20, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 20, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 30, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 17, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 17, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Nov 17, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 17, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 17, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 17, 2022ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Nov 8, 2022PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Oct 26, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 24, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 24, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 22, 2022ALIEASSIGNED TO LIE—
Sep 13, 2022ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 28, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 27, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 27, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Oct 27, 2021CNSLSUSPENSION LETTER WRITTEN—
Oct 19, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 19, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 19, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 22, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2021DOCKASSIGNED TO EXAMINER—
Apr 7, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 11, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance